• Introduced
    Jan 28, 2026
  • Passed House
    Feb 11, 2026
  • Passed Senate
    Feb 26, 2026
  • Became Law
    Mar 09, 2026
HB 1169
South Dakota House Bill
Did you know we offer free bill tracking in Congress and 50 states, AI tools to streamline your work, and a great mobile app? Sign up here
classify medetomidine as a Schedule III controlled substance and establish permissible uses.
Last Action See all actions
executive • Mar 09, 2026: Signed by the Governor, H.J. 534

Summary

Comments on HB 1169

Tweets

Whip Lists

Sponsors
Votes
Actions
  • Mar 09, 2026 | executive
    • Signed by the Governor, H.J. 534
  • Mar 04, 2026 | House
    • Delivered to the Governor, H.J. 497
  • Mar 03, 2026 | Senate
    • Signed by the President, S.J. 448
  • Mar 02, 2026 | House
    • Signed by the Speaker, H.J. 477
  • Feb 26, 2026 | Senate
    • Do Pass, Passed YEAS: 32, NAYS: 0, S.J. 412
  • Feb 25, 2026 | Senate
    • Health and Human Services Scheduled for hearing, S.J. 1
    • Health and Human Services Do Pass, Passed YEAS: 7, NAYS: 0, S.J. 21
    • Health and Human Services Certified uncontested, placed on consent, S.J. 21
  • Feb 12, 2026 | Senate
    • First read in Senate and referred to Health and Human Services, S.J. 260
  • Feb 11, 2026 | House
    • Do Pass, Passed YEAS: 63, NAYS: 3, H.J. 295
  • Feb 10, 2026 | House
    • Health and Human Services Scheduled for hearing
    • Health and Human Services Do Pass, Passed YEAS: 11, NAYS: 0
    • Health and Human Services Certified uncontested, placed on consent
  • Jan 28, 2026 | House
    • First read in House and referred to Health and Human Services, H.J. 163
Documents
Looks like we don't have any documents available at this moment.